Last Updated: 02/12/2024
Enhanced identification of targets of immunity to advance P. vivax vaccine development
Objectives
This proposal sets to rapidly identify multiple new vaccine candidates enabling development of a P. vivax vaccine using the new insights and recently developed novel high-throughput assays.
Principal Institution
Principal Investigators / Focal Persons
Rationale and Abstract
Malaria remains a leading cause of deaths globally. Plasmodium vivax is the major malaria causing parasite outside Africa, but little progress has been made towards development of a P. vivax vaccine. This research recently discovered new ways in which antibodies work in targeting and killing parasites and protecting against malaria.
External reference
Date
Jan 2020 — Dec 2022
Total Project Funding
$423,154
Funding Details
National Health and Medical Research Council (NHMRC) Australia, Australia
Grant ID: 1184836
AUD 608,764
Project Site
Deep Dives
Related Resources
